Company: BIAF
Filing Date: 2025-09-03
Form Type: 8-K
Source: 0001641172-25-026403
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-03
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01. Other Events.

On
September 3, 2025, bioAffinity Technologies, Inc., a Delaware corporation, (the “ Company”) issued a press release announcing
that U. S. Medicine Magazine has featured CyPath® Lung in its pulmonary issue, highlighting the test’s potential to improve
lung cancer detection while lowering costs for the Department of Veterans Affairs (VA).

A
copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.